SAMANTHA MARTIN: Open Payments
NPI 1316468465 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 21 payments from 10 companies in 2025. Trend: 2023 $686 · 2024 $843 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Janssen Biotech, Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Incyte Corporation | 2 | $48 |
| UCB, Inc. | 1 | $33 |
| ConvaTec Inc. | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| Galderma Laboratories, L.P. | 2 | $30 |
| GENZYME CORPORATION | 1 | $25 |
Products named: DUPIXENT, TREMFYA, EBGLYSS, OPZELURA, COSENTYX, Bimzelx, INNOVAMATRIX AC, ILUMYA.
Industry payments across VA — which companies pay providers there.
